In the present study, a three-gene prognostic signature, consisting of ZC3H13, YTHDC1, and YTHDF1, was developed and demonstrated good performance for predicting the survival outcome of CESC. This evidence concerns the gene YTHDC1 and cervical squamous cell carcinoma.